LactoVance is seeking strategic partners and investors to accelerate clinical trials, strengthen validation, and move confidently from evidence to commercial launch and scale with MastisGUARD™.
MastisGUARD™ is positioned as evidence-aligned and veterinarian-guided. Trial protocols and product claims should align with final study outcomes and applicable requirements.


MastisGUARD™ is being built as a differentiated udder-health adjunct with a clinical validation pathway. Partners and investors help turn a strong concept into verified outcomes and scalable distribution.
We welcome structured partnerships that accelerate clinical execution and commercialization while keeping scientific credibility strong at every step.



A simple, investor-friendly progression that builds evidence at each gate before moving forward.
If you are an investor, distributor, veterinary network, or strategic partner, we can share the trial brief, partner package, and financial model. Reach out and we'll align on the best structure for collaboration.
Disclaimer: Informational overview only. Any claims or performance statements should align with finalized protocols, results, and applicable regulatory requirements.